Neuberger Berman, an investment management firm, led a $160m Series D funding round in Akili Interactive, a prescription digital medicine company. The round had participation from investors Polaris Partners, Mirae Assets, Shionogi, New Leaf Venture Partners; Dave Baszucki, QUAD Investment, Ladera Venture Partners, Temasek, Baillie Gifford, JAZZ Venture Partners, Evidity Health Capital, Omidyar Technology Ventures, Fearless Ventures, Amgen Ventures, and M Ventures. "This is the latest milestone in what has been a revolutionary journey for Akili. It will enable us to bring EndeavorRx to as many appropriate patients as possible, advance our core technology, expand our global footprint, and fund research across a wide range of cognitive impairments," Santosh Shanbhag, Akili CFO.